BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 26198850)

  • 1. Cell death induction by the BH3 mimetic GX15-070 in thyroid carcinoma cells.
    Broecker-Preuss M; Viehof J; Jastrow H; Becher-Boveleth N; Fuhrer D; Mann K
    J Exp Clin Cancer Res; 2015 Jul; 34(1):69. PubMed ID: 26198850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Death Induction by the Indirubin Derivative 7BIO and the BH3 Mimetic Drugs ABT-737 and GX15-070 in Medullary Thyroid Carcinoma Cells.
    Broecker-Preuss M; Becher-Boveleth N; Mann K
    Exp Clin Endocrinol Diabetes; 2016 May; 124(5):324-30. PubMed ID: 26849668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells.
    Broecker-Preuss M; Becher-Boveleth N; Müller S; Mann K
    Cancer Cell Int; 2016; 16():27. PubMed ID: 27042160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status.
    Broecker-Preuss M; Müller S; Britten M; Worm K; Schmid KW; Mann K; Fuhrer D
    BMC Cancer; 2015 Mar; 15():184. PubMed ID: 25879531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of atypical cell death in thyroid carcinoma cells by the indirubin derivative 7-bromoindirubin-3'-oxime (7BIO).
    Broecker-Preuss M; Becher-Boveleth N; Gall S; Rehmann K; Schenke S; Mann K
    Cancer Cell Int; 2015; 15():97. PubMed ID: 26464561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GX15-070 (obatoclax) overcomes glucocorticoid resistance in acute lymphoblastic leukemia through induction of apoptosis and autophagy.
    Heidari N; Hicks MA; Harada H
    Cell Death Dis; 2010 Sep; 1(9):e76. PubMed ID: 21364679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells.
    Pérez-Galán P; Roué G; López-Guerra M; Nguyen M; Villamor N; Montserrat E; Shore GC; Campo E; Colomer D
    Leukemia; 2008 Sep; 22(9):1712-20. PubMed ID: 18596739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of chloroquine and GX15-070 (obatoclax) results in synergistic cytotoxicity against pancreatic cancer cells.
    Wang G; Chen S; Edwards H; Cui X; Cui L; Ge Y
    Oncol Rep; 2014 Dec; 32(6):2789-94. PubMed ID: 25333301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Bcl-2 antisense oligonucleotide on drug-sensitivity in association with apoptosis in undifferentiated thyroid carcinoma.
    Kim R; Tanabe K; Uchida Y; Emi M; Toge T
    Int J Mol Med; 2003 Jun; 11(6):799-804. PubMed ID: 12736725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GX15-070 (obatoclax) induces apoptosis and inhibits cathepsin D- and L-mediated autophagosomal lysis in antiestrogen-resistant breast cancer cells.
    Schwartz-Roberts JL; Shajahan AN; Cook KL; Wärri A; Abu-Asab M; Clarke R
    Mol Cancer Ther; 2013 Apr; 12(4):448-59. PubMed ID: 23395885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.
    Zeybek ND; Gulcelik NE; Kaymaz FF; Sarisozen C; Vural I; Bodur E; Canpinar H; Usman A; Asan E
    J Endocrinol; 2011 Jul; 210(1):105-15. PubMed ID: 21478229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.
    Mitsiades CS; McMillin D; Kotoula V; Poulaki V; McMullan C; Negri J; Fanourakis G; Tseleni-Balafouta S; Ain KB; Mitsiades N
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4013-21. PubMed ID: 16849420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth arrest and induction of apoptotic and non-apoptotic programmed cell death by, Physalis minima L. chloroform extract in human ovarian carcinoma Caov-3 cells.
    Ooi KL; Muhammad TS; Sulaiman SF
    J Ethnopharmacol; 2010 Mar; 128(1):92-9. PubMed ID: 20045455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteasome inhibitors synergize with tumor necrosis factor-related apoptosis-induced ligand to induce anaplastic thyroid carcinoma cell death.
    Conticello C; Adamo L; Giuffrida R; Vicari L; Zeuner A; Eramo A; Anastasi G; Memeo L; Giuffrida D; Iannolo G; Gulisano M; De Maria R
    J Clin Endocrinol Metab; 2007 May; 92(5):1938-42. PubMed ID: 17327374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells.
    Pan J; Cheng C; Verstovsek S; Chen Q; Jin Y; Cao Q
    Cancer Lett; 2010 Jul; 293(2):167-74. PubMed ID: 20153924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of low and high concentrations of antitumour drug taxol in anaplastic thyroid cancer cells.
    Pushkarev VM; Starenki DV; Saenko VA; Yamashita S; Kovzun OI; Popadiuk ID; Pushkarev VV; Tronko MD
    Exp Oncol; 2009 Mar; 31(1):16-21. PubMed ID: 19300411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid sensitizes TRAIL-resistant anaplastic thyroid carcinoma cells to apoptotic cell death.
    Cha HY; Lee BS; Kang S; Shin YS; Chang JW; Sung ES; Kim YS; Choi JW; Kim JH; Kim CH
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S716-24. PubMed ID: 23982257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I
    Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a synthetic chenodeoxycholic acid derivative, or lactacystin.
    Kim TH; Yoo YH; Kang DY; Suh H; Park MK; Park KJ; Kim SH
    Int J Oncol; 2009 May; 34(5):1353-62. PubMed ID: 19360347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective activity of BS-RNase against anaplastic thyroid cancer.
    Kotchetkov R; Cinatl J; Krivtchik AA; Vogel JU; Matousek J; Pouckova P; Kornhuber B; Schwabe D; Cinatl J
    Anticancer Res; 2001; 21(2A):1035-42. PubMed ID: 11396137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.